LOADING
Comparing Johnson & Johnson (JNJ) and Merck & Company (MRK), both in the Health Care sector. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $244.01 | $123.50 |
| Change Today | +1.25% | +2.40% |
| Market Cap | -- | $295.4B |
| P/E Ratio | -- | 33.7 |
| Forward P/E | -- | 23.6 |
| PEG Ratio | -- | 5.56 |
| EPS | -- | $3.55 |
| Revenue Growth (YoY) | -- | 4.9% |
| Profit Margin | -- | 13.6% |
| Return on Equity | -- | 18.9% |
| Dividend Yield | -- | 2.84% |
| Beta | -- | 0.22 |
| 52-Week High | -- | $123.33 |
| 52-Week Low | -- | $74.18 |
| Volume | 115K | 169K |